Literature DB >> 26405572

Cross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103- and XCR1+CD103+ dendritic cells.

Ben Wylie1, Elke Seppanen1, Kun Xiao2, Rachael Zemek1, Damien Zanker2, Sandro Prato3, Bree Foley1, Prue H Hart1, Richard A Kroczek4, Weisan Chen2, Jason Waithman1.   

Abstract

The question of which dendritic cells (DCs) cross-present peripheral tumor antigens remains unanswered. We assessed the ability of multiple skin-derived and lymphoid resident DCs to perform this function in a novel orthotopic murine melanoma model where tumor establishment and expansion is within the skin. Two migratory populations defined as CD103-XCR1+ and CD103+XCR1+ efficiently cross-presented melanoma-derived antigen, with the CD103-XCR1+ DCs surprisingly dominating this process. These results are critical for understanding how antitumor CD8+ T cell immunity is coordinated to tumor antigens present within the skin.

Entities:  

Keywords:  Cancer; cross-presentation; dendritic cells; melanoma; tumor immunity

Year:  2015        PMID: 26405572      PMCID: PMC4570138          DOI: 10.1080/2162402X.2015.1019198

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  46 in total

1.  Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α+ type.

Authors:  Karine Crozat; Samira Tamoutounour; Thien-Phong Vu Manh; Even Fossum; Hervé Luche; Laurence Ardouin; Martin Guilliams; Hiroaki Azukizawa; Bjarne Bogen; Bernard Malissen; Sandrine Henri; Marc Dalod
Journal:  J Immunol       Date:  2011-09-23       Impact factor: 5.422

2.  Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice.

Authors:  Rachel A Reboulet; Cassandra M Hennies; Zacarias Garcia; Stefan Nierkens; Edith M Janssen
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

3.  Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells.

Authors:  Jason Waithman; Rhys S Allan; Hiroshi Kosaka; Hiroaki Azukizawa; Ken Shortman; Manfred B Lutz; William R Heath; Francis R Carbone; Gabrielle T Belz
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

4.  Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells.

Authors:  Sammy Bedoui; Paul G Whitney; Jason Waithman; Liv Eidsmo; Linda Wakim; Irina Caminschi; Rhys S Allan; Magdalena Wojtasiak; Ken Shortman; Francis R Carbone; Andrew G Brooks; William R Heath
Journal:  Nat Immunol       Date:  2009-04-06       Impact factor: 25.606

5.  Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures.

Authors:  Shalin H Naik; Anna I Proietto; Nicholas S Wilson; Aleksandar Dakic; Petra Schnorrer; Martina Fuchsberger; Mireille H Lahoud; Meredith O'Keeffe; Qi-xiang Shao; Wei-feng Chen; José A Villadangos; Ken Shortman; Li Wu
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

Review 6.  Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny.

Authors:  Martin Guilliams; Florent Ginhoux; Claudia Jakubzick; Shalin H Naik; Nobuyuki Onai; Barbara U Schraml; Elodie Segura; Roxane Tussiwand; Simon Yona
Journal:  Nat Rev Immunol       Date:  2014-07-18       Impact factor: 53.106

7.  The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin.

Authors:  Laura K Mackay; Azad Rahimpour; Joel Z Ma; Nicholas Collins; Angus T Stock; Ming-Li Hafon; Javier Vega-Ramos; Pilar Lauzurica; Scott N Mueller; Tijana Stefanovic; David C Tscharke; William R Heath; Michael Inouye; Francis R Carbone; Thomas Gebhardt
Journal:  Nat Immunol       Date:  2013-10-27       Impact factor: 25.606

8.  Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells.

Authors:  Brigitte G Dorner; Martin B Dorner; Xuefei Zhou; Corinna Opitz; Ahmed Mora; Steffen Güttler; Andreas Hutloff; Hans W Mages; Katja Ranke; Michael Schaefer; Robert S Jack; Volker Henn; Richard A Kroczek
Journal:  Immunity       Date:  2009-11-12       Impact factor: 31.745

9.  Expression of XCR1 Characterizes the Batf3-Dependent Lineage of Dendritic Cells Capable of Antigen Cross-Presentation.

Authors:  Annabell Bachem; Evelyn Hartung; Steffen Güttler; Ahmed Mora; Xuefei Zhou; Anika Hegemann; Maud Plantinga; Elisa Mazzini; Patrizia Stoitzner; Stephanie Gurka; Volker Henn; Hans W Mages; Richard A Kroczek
Journal:  Front Immunol       Date:  2012-07-18       Impact factor: 7.561

10.  Resident CD8(+) and migratory CD103(+) dendritic cells control CD8 T cell immunity during acute influenza infection.

Authors:  Jason Waithman; Damien Zanker; Kun Xiao; Sara Oveissi; Ben Wylie; Royce Ng; Lars Tögel; Weisan Chen
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

View more
  15 in total

1.  Impaired T cell proliferation by ex vivo BET-inhibition impedes adoptive immunotherapy in a murine melanoma model.

Authors:  Jonathan Chee; Chelsea Wilson; Anthony Buzzai; Ben Wylie; Catherine A Forbes; Mitchell Booth; Nicola Principe; Bree Foley; Mark N Cruickshank; Jason Waithman
Journal:  Epigenetics       Date:  2019-08-26       Impact factor: 4.528

2.  Tissue-resident memory T cells keep cancer dormant.

Authors:  Sarah Sharon Gabriel; Axel Kallies
Journal:  Cell Res       Date:  2019-05       Impact factor: 25.617

Review 3.  Trial watch: Immune checkpoint blockers for cancer therapy.

Authors:  Claire Vanpouille-Box; Claire Lhuillier; Lucillia Bezu; Fernando Aranda; Takahiro Yamazaki; Oliver Kepp; Jitka Fucikova; Radek Spisek; Sandra Demaria; Silvia C Formenti; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-08-31       Impact factor: 8.110

4.  Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cells.

Authors:  Lucy W Barrett; Vanessa S Fear; Bree Foley; Katherine Audsley; Samantha Barnes; Hannah Newnes; Alison McDonnell; Fiona M Wood; Mark W Fear; Jason Waithman
Journal:  Burns Trauma       Date:  2022-04-29

5.  Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors.

Authors:  Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncotarget       Date:  2017-01-24

Review 6.  Modulation of antigen presenting cell functions during chronic HPV infection.

Authors:  Abate Assefa Bashaw; Graham R Leggatt; Janin Chandra; Zewen K Tuong; Ian H Frazer
Journal:  Papillomavirus Res       Date:  2017-08-18

7.  Acquired resistance during adoptive cell therapy by transcriptional silencing of immunogenic antigens.

Authors:  Ben Wylie; Jonathan Chee; Catherine A Forbes; Mitchell Booth; Shane R Stone; Anthony Buzzai; Ana Abad; Bree Foley; Mark N Cruickshank; Jason Waithman
Journal:  Oncoimmunology       Date:  2019-06-03       Impact factor: 8.110

8.  Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy.

Authors:  Emily Gwyer Findlay; Andrew J Currie; Ailiang Zhang; Jana Ovciarikova; Lisa Young; Holly Stevens; Brian J McHugh; Marta Canel; Mohini Gray; Simon W F Milling; John D M Campbell; John Savill; Alan Serrels; Donald J Davidson
Journal:  Oncoimmunology       Date:  2019-05-01       Impact factor: 8.110

Review 9.  The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses.

Authors:  Jorge A Soto; Nicolas M S Gálvez; Catalina A Andrade; Gaspar A Pacheco; Karen Bohmwald; Roslye V Berrios; Susan M Bueno; Alexis M Kalergis
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

10.  CD8+XCR1neg Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic Receptors.

Authors:  Ben Wylie; James Read; Anthony C Buzzai; Teagan Wagner; Niamh Troy; Genevieve Syn; Shane R Stone; Bree Foley; Anthony Bosco; Mark N Cruickshank; Jason Waithman
Journal:  Front Immunol       Date:  2019-01-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.